Litcius/Paper detail

Native LC–MS for capturing quality attributes of biopharmaceuticals on the intact protein level

Florian Füssl, Lisa Strasser, Sara Carillo, Jonathan Bones

2021Current Opinion in Biotechnology42 citationsDOIOpen Access PDF

Abstract

Intact protein analysis by means of mass spectrometry has become a well-established method for the characterization of biotherapeutics. However, due to the highly complex nature of recombinant proteins, prior chromatographic separation is inevitable for a comprehensive analysis. In recent years, progress in coupling a variety of liquid chromatography-based native separation modes such as size exclusion, ion exchange and hydrophobic interaction chromatography to mass spectrometry (native LC-MS) has been reported, therefore allowing for rapid assessment of molecular mass and deep characterization of the heterogeneity of complex, recombinantly produced therapeutic proteins. Here we provide a comprehensive overview of recent advances in the development and application of native LC-MS for biopharmaceutical characterization.

Topics & Concepts

BiopharmaceuticalChromatographyMass spectrometryChemistryCharacterization (materials science)Size-exclusion chromatographyLiquid chromatography–mass spectrometryHydrophilic interaction chromatographySeparation methodHigh-performance liquid chromatographyNanotechnologyBiologyBiochemistryBiotechnologyMaterials scienceEnzymeProtein purification and stabilityMass Spectrometry Techniques and ApplicationsAnalytical Chemistry and Chromatography